Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
Celetrix is at the frontier of next-generation immunotherapy and gene therapy technologies with the new high efficiency electroporation technologies. Celetrix is the technical leader in the field of electroporation for CAR expression in CAR-T therapy and for Cas9 RNP mediated genome editing for gene therapies. The Celetrix electroporation technology is poised to disrupt the viral-vector delivery market with the higher efficiency and the quicker cell manufacturing. Celetrix has issued patents in the US, China and Japan and more pending patent applications worldwide.
Language:
English
Who can attend? Everyone
Featured Presenters
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.